202 related articles for article (PubMed ID: 6264640)
1. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
4. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
[TBL] [Abstract][Full Text] [Related]
5. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
6. Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level.
Luby JP; Ware AJ; Hull AR; Helderman JH; Gailiunas P; Butler S; Atkins C
Arch Intern Med; 1983 Jun; 143(6):1126-9. PubMed ID: 6305295
[TBL] [Abstract][Full Text] [Related]
7. [Primary cytomegalovirus infection as a risk factor following kidney transplantation].
Kaden J; Adamczyk G; Groth J; May G; Janisch W; Scholz D; Topel WR
Z Urol Nephrol; 1983 Oct; 76(10):625-32. PubMed ID: 6318475
[TBL] [Abstract][Full Text] [Related]
8. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
9. [Mortality in pediatric renal transplants: 15 years' experience].
Harzallah K; Floret D; Martin X; Cochat P
Arch Pediatr; 2004 Aug; 11(8):916-20. PubMed ID: 15288081
[TBL] [Abstract][Full Text] [Related]
10. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictive factors for cytomegalovirus infection in renal transplant recipients.
Corona-Nakamura AL; Monteón-Ramos FJ; Troyo-Sanromán R; Arias-Merino MJ; Anaya-Prado R
Transplant Proc; 2009; 41(6):2412-5. PubMed ID: 19715936
[TBL] [Abstract][Full Text] [Related]
12. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
Kasiske BL; Heim-Duthoy KL; Tortorice KL; Ney AL; Odland MD; Rao KV
Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
[TBL] [Abstract][Full Text] [Related]
13. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
Chatterjee SN; Jordan GW
Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
[TBL] [Abstract][Full Text] [Related]
15. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.
Simmons RL; Matas AJ; Rattazzi LC; Balfour HH; Howard JR; Najarian JS
Surgery; 1977 Nov; 82(5):537-46. PubMed ID: 199956
[TBL] [Abstract][Full Text] [Related]
17. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
Ahsan N; Holman MJ; Yang HC
Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
[TBL] [Abstract][Full Text] [Related]
20. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
